Lifen Ren-Heidenreich Selected Research

Paraffin

9/2012	Detection of EGFR somatic mutations in non-small cell lung cancer (NSCLC) using a novel mutant-enriched liquidchip (MEL) technology.
2/2011	A novel liquidchip platform for simultaneous detection of 70 alleles of DNA somatic mutations on EGFR, KRAS, BRAF and PIK3CA from formalin-fixed and paraffin-embedded slides containing tumor tissue.
8/2010	A novel mutant-enriched liquidchip technology for the qualitative detection of somatic mutations in KRAS gene from both serum and tissue samples.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lifen Ren-Heidenreich Research Topics

Disease

5	Neoplasms (Cancer) 11/2013 - 10/2002
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2013 - 09/2012
2	Colorectal Neoplasms (Colorectal Cancer) 08/2010 - 10/2002
1	Lung Neoplasms (Lung Cancer) 11/2013
1	Retinoblastoma (Glioblastoma, Retinal) 12/2004
1	Adenocarcinoma 03/2004

Drug/Important Bio-Agent (IBA)

3	Formaldehyde (Formol)FDA Link 09/2012 - 08/2010
3	ParaffinIBA 09/2012 - 08/2010
2	DNA (Deoxyribonucleic Acid)IBA 11/2013 - 02/2011
2	Tyrosine Kinase InhibitorsIBA 11/2013 - 02/2011
2	ErbB Receptors (EGF Receptor)IBA 11/2013 - 02/2011
2	Epithelial Cell Adhesion MoleculeIBA 12/2004 - 03/2004
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 11/2013
1	Monoclonal AntibodiesIBA 12/2004
1	Interleukin-2 (IL2)IBA 03/2004
1	AntigensIBA 03/2004
1	Chimeric Antigen ReceptorsIBA 10/2002
1	Neoplasm Antigens (Tumor Antigens)IBA 10/2002
1	zeta chain antigen T cell receptor (TCR zeta chain)IBA 10/2002
1	CytokinesIBA 10/2002

Therapy/Procedure

2	Therapeutics 02/2011 - 12/2004
1	Immunotherapy 10/2002